What is ADMA Biologics's net operating loss carryforwards?

ADMA Biologics (ADMA) reported net operating loss carryforwards of $64.43M in Q4 2025.

What does net operating loss carryforwards mean?

These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.

ADMA Biologics ADMA Net Operating Loss Carryforwards

Net Operating Loss Carryforwards at other companies

CHE

ChemedCHE

$52M+32.0%

Mineralys Therapeutics, Inc.MLYS

$59.5M+246%

Cal-Maine FoodsCALM

$6K-72.7%

Crane NXT, Inc.CXT

$53.3M+15.6%

Pathward Financial, Inc.CASH

$3.6M+20.0%

Moelis & CompanyMC

$103.08M-27.6%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's net operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's net operating loss carryforwards?: ADMA Biologics (ADMA) reported net operating loss carryforwards of $64.43M in Q4 2025.
What does net operating loss carryforwards mean?: These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.